PubRank

Chang Ki Min

Author PubWeight™ 11.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res 2008 1.90
2 Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica 2010 1.16
3 Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study. Am J Hematol 2014 1.13
4 Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party. Int J Hematol 2010 0.96
5 Radiologic features of all-trans-retinoic acid syndrome. AJR Am J Roentgenol 2002 0.94
6 Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial. Korean J Intern Med 2002 0.83
7 Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings. Korean J Radiol 2004 0.83
8 The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia. Biol Blood Marrow Transplant 2010 0.82
9 Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas. Pathology 2009 0.80
10 Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma. J Korean Med Sci 2011 0.77
11 Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience. Clin Nephrol 2012 0.75
12 Role of type II NKT cells in the suppression of graft-versus-host disease. Crit Rev Immunol 2008 0.75
13 Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas. APMIS 2009 0.75
14 Absence of JAK1 exon 10 and 13 mutations in acute leukemias and multiple myelomas. Eur J Haematol 2008 0.75
15 Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood. Int J Hematol 2002 0.75